pharma · Metastatic Prostate Cancer · Prostate Cancer · TLX
Telix Innovations
Telix Innovations clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Rue de Hermée 255, Herstal, Région wallonne 4040, BE HQ
2015 Founded
14 Employees
Public company Type
TLX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Rue de Hermée 255, Herstal, Région wallonne 4040, BE
- Founded
- 2015
- Employees
- 14
- Programs
- 27
- Drugs
- 11
- Patents
- 3
Telix Innovations projects
0 ClinicalTrials.gov programs sponsored by Telix Innovations.
Telix Innovations has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Telix Innovations have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.